It is very difficult to measure the problem of counterfeiting accurately from year to year; by definition criminals don?t file tax returns or publish quarterly earnings.
Mark Davison
Advertisement
Mark Davison is CEO at Blue Sphere Health Ltd and the author of Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs and Pharmaceutical Serialisation: Opportunity or Perfect Storm.www.bluespherehealth.com
Articles by Mark Davison
The effects of counterfeiting are hard to measure, both in human impact and financial loss.
The effects of counterfeiting are hard to measure, both in human impact and financial loss.
Advertisement
Latest Updated Articles
Applying Universal Anticounterfeiting TechnologiesPublished: November 1st 2011 | Updated:
Obstacles To Implementing An Effective Anti-Counterfeiting Strategy: Can They Be Overcome?Published: July 1st 2010 | Updated:
Obstacles to implementing an effective anti-counterfeit strategy: can they be overcome?Published: July 1st 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
3
PharmTech Weekly News Roundup — Week of November 10, 2025
4
